To determine the impact of initial antimicrobial choice on 30-day mortality rate in patients
with community-acquired pneumonia due to Streptococcus pneumoniae (CAP-SP), a …

To assess the association between inclusion of a macrolide in a β-lactam—based empirical
antibiotic regimen and mortality among patients with bacteremic pneumococcal pneumonia …

We set out to determine the factors influencing mortality in 125 adult patients with
bacteraemic pneumococcal community-acquired pneumonia (CAP), assessing the impact …

OBJECTIVE The objective of the present study was to compare antibiotic prescribing
practices and survival in the ICU for patients with pneumococcal severe community-acquired …

Rationale Host and bacterial factors as well as different treatment regimens are likely to
influence the outcome in patients with bacteraemic pneumococcal pneumonia. Objectives …

Background Although antibiotic de-escalation is regarded as a measure that reduces
selection pressure, adverse drug effects and costs, evidence supporting this practice in …

Limited data are available about the impact of antimicrobial resistance on clinical outcomes
in cases of pneumococcal pneumonia. This was studied in 146 persons hospitalized with …

Streptococcus pneumoniae is responsible for two-thirds of ICU admissions due to
community-acquired pneumonia (CAP) and is the leading cause of CAP-related death. Early …

Multiple severity scoring systems have been devised and evaluated in community-acquired
pneumonia (CAP), but a simplified set of prognostic indicators has not yet been developed …

Easily performed prognostic rules are helpful for guiding the intensity of monitoring and
treatment of patients. The aim of the present study was to compare the predictive value of the …